|
Market Closed -
Nasdaq
04:00:00 12/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.3204 USD | +0.79% |
|
-18.16% | -67.96% |
| 09-03 | Needham Downgrades TScan Therapeutics to Hold From Buy | MT |
| 09-02 | Wedbush Downgrades TScan Therapeutics to Neutral From Outperform, Adjusts Price Target to $1 From $5 | MT |
| Market Cap | 21.72M 18.71M 17.72M 16.06M 30.13M 2.07B 30.28M 210M 80.92M 1.06B 81.56M 79.77M 3.34B | P/E 2026 * |
-0.4x | P/E 2027 * | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | -77.15M -66.47M -62.94M -57.05M -107M -7.37B -108M -748M -287M -3.75B -290M -283M -11.85B | EV / Sales 2026 * |
-17.1x | EV / Sales 2027 * | -16.2x |
| Free-Float |
93.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TCRX | Delayed | |
CBOE
| TCRX | Real-time |
Last Transcript : TScan Therapeutics, Inc.
| 1 day | +0.79% | ||
| 1 week | -18.16% | ||
| Current month | -56.09% | ||
| 1 month | -58.55% | ||
| 3 months | -64.87% | ||
| 6 months | -71.65% | ||
| Current year | -67.96% |
| 1 week | 0.31 |  | 0.38 |
| 1 month | 0.31 | | 0.84 |
| Current year | 0.31 | | 1.47 |
| 1 year | 0.31 | | 2.57 |
| 3 years | 0.31 | | 9.69 |
| 5 years | 0.31 | | 9.69 |
| 10 years | 0.31 | | 14.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin MacBeath
CEO | Chief Executive Officer | 56 | 28/03/2023 |
Dawn Pinchasik
CTO | Chief Tech/Sci/R&D Officer | - | 06/02/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Katina Dorton
BRD | Director/Board Member | 68 | 23/03/2021 |
Gavin MacBeath
BRD | Director/Board Member | 56 | 24/05/2023 |
Stephen Biggar
CHM | Chairman | 55 | 12/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/5/26 | Free | Director | 67,000 | 0.1200% | ||
| 20/5/26 | Free | Director | 67,000 | 0.1200% | ||
| 20/5/26 | Free | Director | 67,000 | 0.1200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.79% | -18.16% | -81.80% | -87.77% | 21.72M | |
| -2.11% | -1.68% | +43.40% | +95.27% | 66.93B | |
| -0.23% | -4.45% | +32.50% | +75.75% | 61.97B | |
| +1.67% | +2.47% | -11.32% | +380.54% | 28.26B | |
| -1.05% | -4.43% | +28.84% | +10.59% | 24.59B | |
| +0.34% | -6.78% | -0.01% | -16.35% | 24.3B | |
| +0.43% | -3.37% | +16.22% | -17.99% | 19.41B | |
| -3.03% | -2.29% | +181.72% | +335.27% | 16.77B | |
| -1.94% | -4.94% | -8.15% | +483.69% | 14.18B | |
| +3.24% | -0.31% | -7.34% | +880.45% | 14B | |
| Average | -0.19% | -4.47% | +19.41% | +213.95% | 27.04B | |
| Weighted average by Cap. | -0.56% | -2.83% | +31.25% | +170.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.51M 3.88M 3.68M 3.33M 6.25M 430M 6.28M 43.65M 16.79M 219M 16.92M 16.55M 692M | 3.28M 2.82M 2.67M 2.42M 4.55M 313M 4.57M 31.75M 12.21M 159M 12.31M 12.04M 503M |
| Net income | -105M -90.35M -85.55M -77.54M -145M -10.02B -146M -1.02B -391M -5.1B -394M -385M -16.1B | -79.1M -68.15M -64.53M -58.49M -110M -7.56B -110M -766M -295M -3.84B -297M -291M -12.15B |
| Net Debt | -98.87M -85.18M -80.66M -73.11M -137M -9.45B -138M -958M -368M -4.81B -371M -363M -15.18B | -74.76M -64.41M -60.99M -55.28M -104M -7.14B -104M -724M -279M -3.63B -281M -275M -11.48B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | US$0.3204 | +0.79% | 873,124 |
| 10/09/26 | US$0.3179 | -3.70% | 804,593 |
| 09/09/26 | US$0.3301 | -4.26% | 704,849 |
| 08/09/26 | US$0.3448 | -11.93% | 1,536,992 |
| 04/09/26 | US$0.3915 | +5.55% | 1,674,586 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TCRX Stock
Select your edition
All financial news and data tailored to specific country editions
